- Discusses cocaine abuse within the context of current principles of psychology, pharmacology, neuroscience, genetics and epidemiology- Chapters are all authored by scientific experts- First of its kind book on cocaine abuse to recognize behavioral/environmental determinants- Coverage is comprehensive- Informative for experts and generalists alike
Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.
Dr. Higgins has received numerous scientific awards, is President-elect of the Division of Psychopharmacology and Substance Use of the American Psychological Association, is Principal and Co-Investigator on numerous federal research grants, and publishes extensively on cocaine abuse in the scientific literature. He earned his Ph.D. from the University of Kansas in 1983. He was a post-doctoral fellow at the Johns Hopkins University School of Medicine from 1983-1984. From 1985-1986, Dr. Higgins was a staff fellow at the Addiction Research Center of the National Institute of Drug Abuse in Baltimore, Maryland. In 1986, he joined the faculty of the University of Vermont where he is now Professor of Psychiatry and Psychology. His research is a blend of laboratory and treatment-outcome research, primarily focused on developing effective treatments for cocaine abuse.
Katz, Jonathan L.
Dr. Jonathan L. Katz received his Ph.D. in Psychology at the University of Maryland in 1973. He received fellowships from the National Institute of Mental Health and the National Institute on Drug Abuse. He obtained postgraduate training in the Laboratory of Psychobiology at the Harvard Medical School. Following that training he was on the research faculty of the Department of Pharmacology at the University of Michigan Medical School from 1980 to 1982. The next year he took a position in the Intramural Research Program of the National Institute on Drug Abuse, where he serves as Chief of the Psychobiology Section. In addition, Dr. Katz holds the position of Adjunct Associate Professor in the Department of Pharmacology and Experimental Therapeutics at the University of Maryland School of Medicine. Dr. Katz engages in public and professional service through several professional societies and government agencies, and has published extensively in the scientific literature.